[go: up one dir, main page]

RS52178B - Formulacije hfa-suspenzija koje sadrže antiholinergik - Google Patents

Formulacije hfa-suspenzija koje sadrže antiholinergik

Info

Publication number
RS52178B
RS52178B YU85904A YUP85904A RS52178B RS 52178 B RS52178 B RS 52178B YU 85904 A YU85904 A YU 85904A YU P85904 A YUP85904 A YU P85904A RS 52178 B RS52178 B RS 52178B
Authority
RS
Serbia
Prior art keywords
hfa
antichlolinergic
formulations containing
suspension formulations
tiotropium bromide
Prior art date
Application number
YU85904A
Other languages
English (en)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS52178(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of YU85904A publication Critical patent/YU85904A/sh
Publication of RS52178B publication Critical patent/RS52178B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Suspenzije kristalnog tiotropijumbromid-monohidrata, u potisnim gasovima HFA 227 i/ili HFA 134a, u datom slučaju u smeši sa jednim ili sa više drugih potisnih gasova, odabranih iz grupe koju čine propan, butan, pentan, dimetiletar, CHCIF2, CH2F2, CF3CH3, izobutan, izopentan i neopentan, gde je tiotropijum bromid prisutan kao jedina aktivna supstanca.Prijava sadrži još 8 patentnih zahteva.
YU85904A 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže antiholinergik RS52178B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum

Publications (2)

Publication Number Publication Date
YU85904A YU85904A (sh) 2006-08-17
RS52178B true RS52178B (sr) 2012-10-31

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
YU85904A RS52178B (sr) 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže antiholinergik

Country Status (27)

Country Link
EP (2) EP1695701B1 (sr)
JP (1) JP4480401B2 (sr)
KR (1) KR101066801B1 (sr)
CN (1) CN1329023C (sr)
AT (1) ATE339953T1 (sr)
AU (1) AU2003209743B2 (sr)
BR (1) BR0308764A (sr)
CA (1) CA2479640C (sr)
CY (1) CY1105543T1 (sr)
DE (2) DE10214263A1 (sr)
DK (1) DK1492513T3 (sr)
EA (1) EA007239B1 (sr)
EC (1) ECSP045321A (sr)
ES (1) ES2273020T3 (sr)
HK (1) HK1079091A1 (sr)
HR (1) HRP20040889B1 (sr)
IL (2) IL163697A0 (sr)
ME (1) ME00247B (sr)
MX (1) MXPA04009337A (sr)
NO (1) NO20044005L (sr)
NZ (1) NZ536043A (sr)
PL (1) PL371296A1 (sr)
PT (1) PT1492513E (sr)
RS (1) RS52178B (sr)
UA (1) UA78557C2 (sr)
WO (1) WO2003082252A1 (sr)
ZA (1) ZA200405638B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809243B2 (de) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US20150250713A1 (en) * 2012-10-23 2015-09-10 Cipla Limited Pharmaceutical Composition
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
BR0114584A (pt) * 2000-10-12 2003-08-26 Boehringer Ingelheim Pharma Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
CA2436540C (en) * 2000-10-31 2008-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
EP1695701B1 (de) 2015-01-07
DE50305118D1 (de) 2006-11-02
YU85904A (sh) 2006-08-17
DE10214263A1 (de) 2003-10-16
WO2003082252A1 (de) 2003-10-09
CY1105543T1 (el) 2010-07-28
CA2479640C (en) 2010-09-28
ATE339953T1 (de) 2006-10-15
PT1492513E (pt) 2006-12-29
CA2479640A1 (en) 2003-10-09
PL371296A1 (en) 2005-06-13
ECSP045321A (es) 2005-01-28
MXPA04009337A (es) 2005-01-25
EP1492513A1 (de) 2005-01-05
JP2005529087A (ja) 2005-09-29
HRP20040889A2 (en) 2004-12-31
HRP20040889B1 (hr) 2012-11-30
CN1642534A (zh) 2005-07-20
ME00247B (me) 2011-05-10
NZ536043A (en) 2005-09-30
AU2003209743B2 (en) 2008-03-06
KR101066801B1 (ko) 2011-09-22
IL163697A0 (en) 2005-12-18
AU2003209743A1 (en) 2003-10-13
CN1329023C (zh) 2007-08-01
JP4480401B2 (ja) 2010-06-16
BR0308764A (pt) 2005-01-11
NO20044005L (no) 2004-10-05
EP1695701A3 (de) 2010-04-28
EP1695701A2 (de) 2006-08-30
MEP47408A (en) 2011-02-10
EA200401190A1 (ru) 2005-04-28
ES2273020T3 (es) 2007-05-01
ZA200405638B (en) 2005-07-27
UA78557C2 (en) 2007-04-10
HK1079091A1 (en) 2006-03-31
EA007239B1 (ru) 2006-08-25
IL163697A (en) 2011-03-31
DK1492513T3 (da) 2006-12-18
EP1492513B1 (de) 2006-09-20
KR20040098031A (ko) 2004-11-18

Similar Documents

Publication Publication Date Title
CA2107232A1 (en) Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
BRPI0809736B8 (pt) composição e processo para produzir refrigeração
ES2127411T3 (es) Composiciones incluyendo 1,1,1,2,3,4,4,5,5,5-decafluoropentano y n-propanol.
AR049660A1 (es) Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion
RS52178B (sr) Formulacije hfa-suspenzija koje sadrže antiholinergik
RS51156B (sr) Inhibitori renina
DE69630454D1 (de) Mikrozellschaum
DK0484530T3 (da) Opskummeligt aerosolpræparat
ATE71295T1 (de) Schaumbare biozidezusammensetzung.
ATA10002000A (de) Antigene zusammensetzung
GB1536813A (en) Propellant compositions for aerosols
RU94046205A (ru) СПОСОБ ИЗГОТОВЛЕНИЯ ПЛИТ ИЗ ПЕНОПЛАСТА НА ОСНОВЕ СТИРОЛЬНЫХ ПОЛИМЕРОВ С МИНИМАЛЬНОЙ ТОЛЩИНОЙ 20 ММ И МИНИМАЛЬНЫМ ПОПЕРЕЧНЫМ СЕЧЕНИЕМ 50 см2
DE60024311D1 (de) Kühlmittelzusammensetzungen
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
ATE225836T1 (de) Kühlmittelzusammensetzung
ID21773A (id) Anestetik lokal untuk penggunaan luar
ES2113550T3 (es) Composiciones azeotropicas o similares a un azeotropo de amoniaco e hidrofluorocarburos.
RS52481B (sr) Formulacija hfa-suspenzije koja sadrži anhidrat
NO20053163D0 (no) Kjolerkuldemedier.
ATE96836T1 (de) Azeotrope von wasserstoff enthaltenden kohlenstoffen mit butanen.
ES2086127T3 (es) Composiciones azeotropicas o semejantes a azeotropos de pentafluoroetano y propano o isobutano.
CA2329989A1 (en) High productivity, low fugitive emission foams and foam processes
ES2093528T3 (es) Composiciones que incluyen un hexafluoropropano.
BR9808818A (pt) Composição constituìda essencialmente de 1, 1, 1, 3, 3-pentafluorobutano e de um hidrocarboneto, utilização de composições azeotrópicas ou pseudo-azeotrópicas, agente espumante para espumas celulares poliméricas e pré-mistura para espuma de poliuretano.
CA2305777A1 (en) High productivity, low fugitive voc emission foam process